Summary by Futu AI
Clover Biopharmaceuticals Limited (“Shamus Bio-B”) filed with Hong Kong Trading and Settlement Limited on February 2, 2024 an updated Monthly Statement of Changes in Securities Reporting for the year ended January 31, 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of $0.0001 per share for a total of $200,000. However, in the area of share options, under the Initial Public Offering (IPO), share options were exercised this month, resulting in the issuance of 653,196 new shares and a corresponding sum of HK$5,225.56. The Company confirms that all newly issued securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.